Valuation: PT Kalbe Farma Tbk.

Market Cap 32,57900Cr 180.59Cr 157.86Cr 145.99Cr 133.96Cr 253.54Cr 17TCr 257.94Cr 1.74TCr 683.93Cr 8.5TCr 678.2Cr 663.3Cr 29TCr P/E 2026 *
9.27x
P/E 2027 * 8.25x
Enterprise Value 2.73TCr 15.15L 13.24L 12.24L 11.23L 21.26L 15Cr 21.63L 1.46Cr 57.36L 7.13Cr 56.88L 55.63L 25Cr EV / Sales 2026 *
0.72x
EV / Sales 2027 * 0.65x
Free-Float
31.79%
Yield 2026 *
5.06%
Yield 2027 * 5.66%
1 day+2.13%
1 week-0.69%
Current month-5.88%
1 month-2.70%
3 months-26.15%
6 months-40.25%
Current year-40.25%
1 week 700
Extreme 700
745
1 month 675
Extreme 675
810
Current year 630
Extreme 630
1,245
1 year 630
Extreme 630
1,560
3 years 630
Extreme 630
2,040
5 years 630
Extreme 630
2,360
10 years 630
Extreme 630
2,360
Manager TitleAgeSince
Chief Executive Officer 64 16/05/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 62 01/01/2008
Chairman 54 22/05/2025
Director/Board Member 54 01/01/2008
Change 5-day change 1-year change 3-year change Capi.($)
+2.13%-0.69%-52.32%-65.22% 176.59Cr
+1.08%-3.93%+48.03%+160.13% 1,03100Cr
+1.19%-3.52%+51.70%+56.36% 59TCr
+4.21%+1.79%+33.48%+87.04% 43TCr
+0.42%-1.16%+29.43%+22.27% 33TCr
+1.03%-0.84%+29.58%+45.08% 28TCr
+0.49%-5.44%+21.00%+22.32% 26TCr
+3.70%+2.19%+24.27%+63.38% 19TCr
+3.49%+1.08%+24.08%+76.58% 16TCr
+1.29%+3.67%+2.15%-30.78% 14TCr
Average +1.63%-0.93%+21.14%+43.72% 34.24TCr
Weighted average by Cap. +1.66%-2.05%+37.06%+82.41%

Financials

2026 *2027 *
Net sales 38,16300Cr 211.55Cr 184.91Cr 171.01Cr 156.92Cr 296.99Cr 20TCr 302.15Cr 2.04TCr 801.15Cr 9.95TCr 794.44Cr 776.99Cr 34TCr 41,32400Cr 229.07Cr 200.23Cr 185.17Cr 169.92Cr 321.59Cr 22TCr 327.18Cr 2.21TCr 867.51Cr 11TCr 860.25Cr 841.35Cr 37TCr
Net income 3,65900Cr 20Cr 18Cr 16Cr 15Cr 28Cr 1.95TCr 29Cr 195.52Cr 77Cr 954.35Cr 76Cr 74Cr 3.29TCr 4,12100Cr 23Cr 20Cr 18Cr 17Cr 32Cr 2.2TCr 33Cr 220.25Cr 87Cr 1.08TCr 86Cr 84Cr 3.71TCr
Net Debt -5,25700Cr -29Cr -25Cr -24Cr -22Cr -41Cr -2.81TCr -42Cr -280.92Cr -110.35Cr -1.37TCr -109.43Cr -107.03Cr -4.73TCr -5,80800Cr -32Cr -28Cr -26Cr -24Cr -45Cr -3.1TCr -46Cr -310.4Cr -121.93Cr -1.52TCr -120.91Cr -118.26Cr -5.23TCr
Logo PT Kalbe Farma Tbk.
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products, including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritional, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over-the-counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
Employees
12,895
Date Price Change Volume
16/26/16 IDR 720.00 +2.13% 9,84,38,200
15/26/15 IDR 705.00 -3.42% 15,66,11,300
14/26/14 IDR 730.00 +0.69% 5,88,09,400
13/26/13 IDR 725.00 0.00% 4,48,99,800
10/26/10 IDR 725.00 0.00% 3,38,49,600
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
720.00IDR
Average target price
1,275.29IDR
Spread / Average Target
+77.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KLBF Stock